Copenhagen-based biotechnology company
Draupnir Bio has raised €12M across 1 funding round from 5 investors, most recently a Seed round in Jul 2024. Based in Copenhagen, Denmark; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-31 | Seed | €12M |
| Export and Investment Fund of Denmark (EIFO),Gilde Healthcare Partners,Inkef Capital,MP Healthcare Venture Management,Novo Holdings |
| View deal → |
